Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The world’s largest clinical trial investigating treatments for COVID-19 has now launched in Ghana, West Africa. This is the sixth country to take part in RECOVERY, joining Indonesia, Nepal, South Africa, Vietnam, and the United Kingdom.

Aerial image of town in Ghana

Since March 2020, the RECOVERY Trial has discovered three effective treatments for COVID-19: the inexpensive steroid dexamethasonethe arthritis drug tocilizumab; and a monoclonal antibody treatment, now known as Ronapreve. However, as the pandemic continues to affect both high and lower income countries, and with the constant threat of new coronavirus variants, treatments are needed that are suitable for a wide range of patients and healthcare systems. Consequently, RECOVERY International was launched in February 2021.

Professor Sir Peter Horby, Joint Chief Investigator of RECOVERY, said: ‘I am thrilled to welcome Ghana to the RECOVERY endeavour to improve the care of patients with severe COVID-19. COVID-19 affects everyone, and we need treatments for everyone, wherever they are and whatever level of healthcare is available to them.’ 

In Ghana, RECOVERY will initially focus on whether using a higher dose of the anti-inflammatory treatment dexamethasone has an even greater effect than the standard doses of the drug previously shown to save lives by the RECOVERY trial. It is likely that empagliflozin, a routine treatment for type 2 diabetes, will also be added to the study in Ghana soon.

The first Ghanaian hospitals taking part in RECOVERY are the Ghana Infectious Disease Centre, Accra, and the Komfo Anokye Teaching Hospital, Kumasi. The study will be open to all hospital patients admitted with confirmed COVID-19. All participants will receive the usual care; some will additionally receive one of the treatments being investigated.

The expansion of RECOVERY International to Ghana is a partnership between the University of Oxford and the Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR).

The full story is available on the RECOVERY website

Similar stories

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Expert Comment: Biotechnology allows us to make unprecedented interventions for conservation

In the wake of high-profile reports on the devastating toll human activity has had on global biodiversity, nations are expected to adopt the Convention on Biodiversity post-2020 framework that outlines measures to ensure humans live in harmony with nature.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy

A new WWARN meta-analysis, commissioned by the World Health Organization and which informed a change to its treatment guidelines, has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

GRAM visualization tool tracks country-level AMR and related metrics

Interactive app allows users to explore data underlying estimates of global AMR burden